BioVentrix

About:

BioVentrix is a medical device company that improves and expands the treatment available for congestive heart failure.

Twitter/X: bioventrix

Top Investors: Andera Partners, Cormorant Asset Management, Squarepoint Capital, Richmond Brothers, Inc., Taglich Brothers

Description:

BioVentrix is a medical device company focusing on the treatment of congestive heart failure. Its mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy through less invasive, catheter-based approaches.

Total Funding Amount:

$230M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Ramon, California, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)bioventrix.com

Founders:

Arthur Bertolero, Lon S. Annest

Number of Employees:

11-50

Last Funding Date:

2023-04-13

IPO Status:

Private

Industries: